Siegfried Holding AG : Strong underlying business offsets multiple temporary headwinds
>A strong set of H1 2024 results – 2024 outlook confirmed - At the group level, Siegfried’s H1 2024 sales of CHF 620m (+2.1%), were above our (CHF 614m) and the consensus estimates (CHF 610m). The group’s core EBITDA of CHF 132m (+5.1%) came in 1% stronger than we expected (CHF 131m) and was 2.3% above the consensus (CHF 129m). The relatively strong increase in the company’s EBITDA and the improvement of its core EBITDA margin 21.3% vs 20.7% in H1 2023 must be seen a...Siegfried Holding is a worldwide pharmaceutical supplier with production sites in Switzerland, Malta, and in the United States. Co. develops manufacturing processes for active pharmaceutical ingredients and their intermediates and manufactures these (Drug Substances). Co. also produces finished pharmaceutical products (Drug Products).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.